When the Mets acquired Yoenis Cespedes in the waning minutes of the 2015 trade deadline, they had to part with one of their top pitching prospects, Michael Fulmer.
The deal arguably worked out for both sides in the short term; Cespedes helped lead the Mets to a pennant that year and re-signed with the team, while Fulmer won the American League Rookie of the Year award in 2016 and was an All-Star the next season. But the righty regressed in 2018 and had knee surgery in September.
Now, Fulmer won't see a mound for quite a while. He has been recommended to have Tommy John surgery, the team said Tuesday, after consulting with the renowned Dr. James Andrews, who also performed Fulmer's knee surgery. Additionally, he will seek a third opinion befor making a final decision.
Fulmer, 26, made his Major League debut about eight months after New York dealt him, going 11-7 with a 3.06 ERA in 26 starts that year. In 2017, he pitched a career-high 164 2/3 innings and posted a 3.83 ERA. Last season was, statistically, his worst campaign, as he set career worsts in ERA (4.69), home runs allowed (19) and WHIP (4.52).
Ironically enough, Cespedes has been oft-injured during his Mets tenure. He played just half of 2017 and 38 games in 2018, while the expectation is he will be out until at least July this year.
Luis Cessa, who is now with the Yankees, was the other player sent from the Mets to the Tigers in the deal.